Holaira Announces Company Name Change to Nuvaira

Minneapolis, Minn., – Holaira, a developer of medical devices to treat obstructive lung diseases, today announced that it has changed its name to Nuvaira, effective immediately. In addition, the company … Continued

Personal Genome Diagnostics Awarded Department of Veterans Affairs Contract for Its PlasmaSELECT Liquid Biopsy Cancer Profiling Assay

  BALTIMORE, MD – Personal Genome Diagnostics Inc. (PGDx) today announced an agreement with the U.S. Department of Veterans Affairs (VA) to provide its PlasmaSELECTTM 64 liquid biopsy profiling assay … Continued

Earlens closes $118m in mixed debt and equity round

Earlens said today it closed a total of $118 million in funding, with $73 million coming from an offering of Series C preferred stock and $45 from a structured debt facility … Continued

Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda® for MSI Tumors

Personal Genome Diagnostics Inc. (PGDx), a pioneer in cancer genomic testing, today highlighted its patent-pending microsatellite instability (MSI) testing technology following the U.S. Food and Drug Administration’s (FDA) accelerated approval … Continued

NeoTract Inc. Announces Cigna Coverage for the UroLift® System for Enlarged Prostate

PLEASANTON, Calif.–(BUSINESS WIRE)–NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced that Cigna, a global health service company that provides insurance … Continued